financetom
Business
financetom
/
Business
/
Oncolytics Biotech Hires Andrew Aromando as Chief Business Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oncolytics Biotech Hires Andrew Aromando as Chief Business Officer
Jun 30, 2025 6:27 AM

09:00 AM EDT, 06/30/2025 (MT Newswires) -- Oncolytics Biotech ( ONCY ) , a clinical-stage company specializing in immunotherapy for oncology, said Monday that it appointed Andrew Aromando as chief business officer.

Aromando has more than 30 years of experience in the life sciences industry and most recently served as chief operating officer of Ambrx Biopharma, Oncolytics said.

Oncolytics' share price gained 6% on Friday to $1.04 on the CSE.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trump to use CFIUS to restrict Chinese investments in strategic areas, White House official says
Trump to use CFIUS to restrict Chinese investments in strategic areas, White House official says
Feb 21, 2025
WASHINGTON (Reuters) -President Donald Trump will sign a memorandum on Friday that will direct the Committee on Foreign Investment in the United States to restrict Chinese investments in strategic areas, a White House official said. The national security memorandum is aimed at promoting foreign investment while protecting U.S. national security interests from threats posed by foreign adversaries like China, the...
Datadog Insider Sold Shares Worth $3,234,692, According to a Recent SEC Filing
Datadog Insider Sold Shares Worth $3,234,692, According to a Recent SEC Filing
Feb 21, 2025
04:10 PM EST, 02/21/2025 (MT Newswires) -- Amit Agarwal, Director, on February 19, 2025, sold 25,000 shares in Datadog ( DDOG ) for $3,234,692. Following the Form 4 filing with the SEC, Agarwal has control over a total of 203,848 Class A common shares of the company, with 195,667 shares held directly and 8,181 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1561550/000156155025000027/xslF345X05/wk-form4_1740171846.xml ...
Entergy Insider Sold Shares Worth $1,810,178, According to a Recent SEC Filing
Entergy Insider Sold Shares Worth $1,810,178, According to a Recent SEC Filing
Feb 21, 2025
04:09 PM EST, 02/21/2025 (MT Newswires) -- Eliecer Viamontes, Officer under Section 16 Rules, on February 20, 2025, sold 21,142 shares in Entergy ( ETR ) for $1,810,178. Following the Form 4 filing with the SEC, Viamontes has control over a total of 14,251 common shares of the company, with 6,924 shares held directly and 7,327 controlled indirectly. SEC Filing:...
Immunovant Insider Sold Shares Worth $322,058, According to a Recent SEC Filing
Immunovant Insider Sold Shares Worth $322,058, According to a Recent SEC Filing
Feb 21, 2025
04:09 PM EST, 02/21/2025 (MT Newswires) -- Peter Salzmann, Director, Chief Executive Officer, on February 19, 2025, sold 15,439 shares in Immunovant ( IMVT ) for $322,058. Following the Form 4 filing with the SEC, Salzmann has control over a total of 948,786 common shares of the company, with 948,786 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000030/xslF345X05/wk-form4_1740171852.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved